CoChat

A nasal proteosome adjuvant activates microglia and prevents amyloid deposition

Open access
Frenkel, Dan, Puckett, Lindsay, Petrovic, Sanja, Xia, Weiming, Chen, Guiquan, Vega, Jose, Dembinsky‐Vaknin, Adi, Shen, Jie, Plante, Martin, Burt, David S., Weiner, Howard L. · 2008 · Annals of Neurology
Cited by 56

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Objective: We assessed whether peripheral activation of microglia by a nasal proteosome‐based adjuvant (Protollin) that has been given safely to humans can prevent amyloid deposition in young mice and affect amyloid deposition and memory function in old mice with a large amyloid load. Methods: Amyloid precursor protein (APP) transgenic (Tg) J20 mice received nasal treatment with Protollin weekly for 8 months beginning at age 5 months. Twenty‐four‐month‐old J20 mice were treated weekly for 6 weeks. Results: We found reduction in the level of fibrillar amyloid (93%), insoluble β‐amyloid (Aβ; 68%), and soluble Aβ (45%) fragments in 14‐month‐old mice treated with Protollin beginning at age 5 months. Twenty‐four‐month‐old mice treated with nasal Protollin for 6 weeks had decreased soluble and insoluble Aβ (1‐40) and (1‐42) and improved memory function. Activated microglia (CD11b + cells) colocalized with Aβ fibrils in the 24‐month‐old animals, and microglial activation correlated with the decrease in Aβ. No microglial activation was observed in 14‐month‐old mice, suggesting that once Aβ is cleared, there is downregulation of microglial activation. Both groups had reduction in astrocytosis. Protollin was observed in the nasal cavity and cervical lymph node but not in the brain. Activated CD11b + SRA + (scavenger receptor A) cells were found in blood and cervical lymph node and increased interleukin‐10 in cervical lymph node. No toxicity was associated with treatment. Interpretation: Our results demonstrate a novel antibody‐independent immunotherapy for both prevention and treatment of Alzheimer's disease that is mediated by peripheral activation of microglia with no apparent toxicity. Ann Neurol 2008;63:591–601

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/ana.21340

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 13 references

Cited by

See all 56

Metadata

Authors
Frenkel, D., Puckett, L., Petrovic, S., Xia, W., Chen, G., Vega, J., Dembinsky‐Vaknin, A., Shen, J., Plante, M., Burt, D. S., & Weiner, H. L.
Venue
Annals of Neurology
Publisher
Wiley
Published
2008-05
Volume
63
Issue
5
Pages
591-601
ISSN
  • 0364-5134 (ISSN-L)
  • 1531-8249
OpenAlex
W1967274572
Cited by
56
References
13
FWCI
2.01
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A nasal proteosome adjuvant activates microglia and prevents amyloid deposition. https://app.cochat.ai/papers/10.1002/ana.21340
The paper
Frenkel, D., Puckett, L., Petrovic, S., Xia, W., Chen, G., Vega, J., Dembinsky‐Vaknin, A., Shen, J., Plante, M., Burt, D. S., & Weiner, H. L. (2008). A nasal proteosome adjuvant activates microglia and prevents amyloid deposition. Annals of Neurology. https://doi.org/10.1002/ana.21340

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.